In the near future, the drug screening industry is poised to undergo a transformative evolution driven by rapid technological advancements and an increasing emphasis on personalized medicine. Cutting-edge technologies such as high-throughput screening, artificial intelligence, and advanced biomarker detection methods will enable more efficient and accurate identification of potential drug candidates, significantly accelerating the drug discovery process. Precision medicine approaches will become increasingly prevalent, tailoring drug screening strategies to individual patients' genetic profiles and health conditions, leading to more targeted and effective treatments. Moreover, the integration of wearable devices, point-of-care testing, and telemedicine will facilitate widespread and convenient drug screening applications, extending beyond clinical settings to empower proactive health management in everyday life. As regulatory frameworks adapt to these innovations, collaborations among pharmaceutical companies, research institutions, technology providers, and healthcare stakeholders will shape a dynamic landscape that strives for safer medications, expedited drug development, and improved patient outcomes.
Drug Screening market in terms of revenue was estimated to be worth $5.3 billion in 2021 and is poised to reach $11.6 billion by 2026, growing at a CAGR of 16.8% from 2021 to 2026 according to a latest report published by MarketsandMarkets™. Growth in this market is attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries are some major factors that may hinder market growth.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773
Drug Screening Market Scope:
| Report Coverage | Details |
| Market Revenue in 2021 | $5.3 billion |
| Estimated Value by 2026 | $11.6 billion |
| Growth Rate | Poised to grow at a CAGR of 16.8% |
| Market Size Available for | 2019-2026 |
| Forecast Period | 2021–2026 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product & Service, Sample type, End User, and Region |
| Geographies Covered | North America (the US and Canada), Asia Pacific (Japan, China, India, and RoPAC), Europe (Germany, UK, France, Italy, Spain and RoE), and the Rest of the World (Latin America, Middle East & Africa) |
| Report Highlights | Updated financial information / product portfolio of players |
| Key Market Opportunities | Emerging economies |
| Key Market Drivers | Growing drug and alcohol consumption |
Drug Screening market major players covered in the report, such as:
- LabCorp (US)
- Quest Diagnostics (US)
- Abbott Laboratories (US)
- Thermo Fisher Scientific, Inc. (US)
- Alfa Scientific Designs, Inc. (US)
- OraSure Technologies, Inc. (US)
- Siemens Healthineers (Germany)
- Roche (Switzerland)
- MPD Inc. (US)
- Shimadzu (Japan)
- LifeLoc Technologies (US)
- Drägerwerk (Germany)
- Premier Biotech, Inc. (US)
- Omega Laboratories, Inc. (US)
- Psychemedics (US)
- Clinical Reference Laboratory (US)
- American Bio Medica Corporation (US)
- ACM Global Laboratories (US)
- CareHealth America Corp (US)
- Sciteck, Inc. (US)
- Synens (France)
- Intoximeters (US)
- AccuSource (US)
- Cordant Health Solutions (US)
- Millennium Health (US)
- and Among Others
Buy a Drug Screening Industry Report (223 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=162987773
The study categorizes the Drug screening market into the following segments and subsegments:
By Product and Service
- Drug Screening Product
- Analytical Instruments
- Breathalyzers
- Fuel Cell Breathalyzer
- Semiconductor Breathalyzer
- Other Breathalyzers
- Immunoassay Analyzer
- Chromatography Instruments
- Breathalyzers
- Rapid Testing Devices
- Urine Testing Devices
- Drug Testing Cups
- Dip Cards
- Drug Testing Cassetts
- Oral Fluid Testing Devices
- Urine Testing Devices
- Consumables
- Assay Kits
- Sample Collection Devices
- Calibrators & Controls
- Other Consumables
- Analytical Instruments
- Drug Screening Service
By Sample Type
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By End User
- Drug Testing Laboratories
- Workplaces
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools and Colleges
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- China
- Japan
- India
- RoAPAC
- Rest of the World
- Latin America
- Middle East & Africa
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773
